Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.

Slides:



Advertisements
Similar presentations
Global Measles and Rubella Strategic Plan
Advertisements

1 |1 | Countries using and planning to introduce IPV July 2014 status report This slide deck provides a summary per country on the status of planning for.
1 June 2011 Measles update- India Dr. Satish Kumar Gupta Health Specialist UNICEF- India 13 th September 2011.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
1 |1 | Countries using and planning to introduce IPV.
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
Vaccine in National Immunization Programme Update March 2015.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
World Health Organization
1 |1 | Countries using and planning to introduce IPV.
TITLE from VIEW and SLIDE MASTER | August 7, |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *
WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
World Health Organization
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
1 |1 | Countries using and planning to introduce IPV.
Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
MEASLES MORTALITY REDUCTION IN INDIA Status and Future Plans.
Update on Measles Mortality Reduction Activities and Linkages with RI.
1 |1 | Countries using and planning to introduce IPV.
8 th Global Measles and Rubella LabNet Meeting, Sept 2010 Key Recommendations GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Salle B, WHO.
1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration Countries using and planning to introduce IPV and the global.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
1 Progress Towards Global and Regional Immunization Goals Workshop on Prevention and Control of Vaccine Preventable Disease in Displaced Person Temporary.
Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012.
AFR MR TAG Global Measles and Rubella Update 5 th African Regional Measles/Rubella TAG Meeting 2 nd -3 rd June 2015.
The changing vaccination landscape and the sources of vaccination data
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
Data in WHO HQ as of 17 Apr 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this document.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
National Influenza Centres in SEA Region Dr Rajesh Bhatia / Dr Oommen John WHO Regional Office for South-East Asia New Delhi 5 th Meeting of NIC in Western.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
PROGRESS TOWARDS MEASLES & RUBELLA ELIMINATION EXPERIENCE FROM OMAN SALAH AL AWAIDY, MD COMMUNICABLE DISEASES ADVISOR MOH, OMAN
World Health Organization Western Pacific Regional Office Expanded Programme on Immunization Measles Elimination in the Western Pacific Region 2007 Partners.
Vaccine in National Immunization Programme Update April 2016.
World Health Organization
Regional WHO Measles and Rubella Focal Point Meeting
reporting rate of discarded cases* per 100'000 population**
World Health Organization
Session 1: New Opportunities and New Direction
Monthly Distribution of Wild Poliovirus Cases1,
Countries Having Introduced Hib Vaccine
Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010
Non-polio AFP Rate July 2014 – June 2015 July 2015 – June 2016
Monthly Distribution of Wild Poliovirus Cases1,
(70 countries or 36%) (23 countries or 12%)
Countries with Genotype data available
Countries Using Hib Vaccine in National Immunization Schedule in 2010 and Countries Approved for GAVI Support for Use from 2011 Onwards Yes (166 countries.
World Health Organization
Countries having introduced HepB vaccine
Countries Using Mening Vaccine in National Immunization Schedule 2011
- Use same categories as for bar chart below Introduced Without GAVI
Onset of most recent case Number of infected districts
Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.
2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)
World Health Organization
World Health Organization
Presentation transcript:

Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development WHO/SEARO

Presentation structure Progress towards the regional goal Summary of achievements and main challenges Plans for

South-East Asia Region 11 diverse countries 1.6 billion; 25% of world’s population Massive immunization burden >500 million children aged <15 years 35 % (11 million infants) un-immunized with 1 st dose of measles vaccine Polio endemic However there is reasonable human resources for EPI in most countries at most levels

Regional Strategic Plan Goal By 2009 reduce the number of estimated measles deaths by 90% in comparison to 2000 Specific objectives 1 st dose measles coverage >90%, nationally and in >80% of districts by 2009 Fully investigate all detected/reported measles outbreaks Case based measles surveillance within integrated surveillance systems in countries that completed catch-up campaigns Provide a second opportunity for measles immunization

WHO/UNICEF estimates for MCV1 coverage Regional coverage increased from 59% in 1999 to 65% in 2005 Source: WHO/UNICEF estimates

Updated Sep 2006 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved Continue to use the surveillance staff in five priority countries in measles surveillance and SIAs

Reported incidence rates of clinically confirmed measles cases in selected countries Data as of 19 Feb 2007 Source: WHO/UNICEF JRF ; Monthly Reporting Form,

Status of SEAR measles laboratory network 16 National Measles laboratories – Expansion in India continues 1 Regional reference laboratory – NIH Bangkok GSL for SEAR - CDC Atlanta Labs perform IgM ELISA confirm Measles / rubella Virus isolation in Vero SLAM - 6 labs in the region. Isolates referred to RRL / GSL - CDC for genotyping 2006 Proficiency testing – 14 laboratories participated – 13 laboratories passed Data management software - MLIS developed

Measles and Rubella Serology (IgM) Results in 2006 All laboratories report data monthly Data as of 31 Dec 2006

Number of suspected measles Outbreaks Investigated SEAR, Source: SEAR EPI Annual Reporting Form, ; Monthly Reporting Form, 2006 (Feb 2007) Number of Outbreaks Investigated Data as of 19 Feb 2007

Vaccine Preventable Diseases reported to SEARO out of 11 countries are reporting monthly Data as of 19 Feb 2007 Source: Monthly Reports from Countries

Age distribution of measles outbreaks Target age group for SIA was based on country age distribution of cases CountryYear*Number of cases** Age (yrs) distribution of cases (%)Target Age group for SIA ≤ ≥15 Bangladesh M-10Y DPR Korea M-45Y Indonesia M-12Y Myanmar M-10 Y Nepal M-15 Y Maldives Y Sri Lanka20006, Y Source: Annual EPI Reporting Form *Most recent year of outbreak in country **Country Report *** only the cases with age known considered Updated as of 19 Feb 2007

Second Opportunity for Measles Immunization, SEAR, 2007 Data as of: Feb 2007 Measles 2 nd Opportunity through Routine Immunization Catch-up Campaigns completed Measles 2 nd Opportunity through Catch-up/Follow up Campaigns 4 Countries providing MR/MMR Catch-up/Follow-up Campaigns planned in 2007

Number of children vaccinated during measles SIA and planned SIAs in SEAR Planned 120 million would be vaccinated by August 2007

Strengthening of measles surveillance and Impact of measles catch-up campaign Bangladesh, Source : Monthly VPD MDB submitted to SEARO Clinically confirmed cases Measles Catch-up Campaign Data as of 19 Feb 2007

Cases reported from serologically confirmed suspected Measles Outbreaks Bangladesh, Source : Monthly VPD XLS Data as of 19 Feb 2007 Measles Catch-up Campaign After the SIA Few measles outbreaks. Rubella outbreaks continue to be detected

Strengthening of Measles surveillance and impact of measles catch-up campaign, Nepal, Data as of 19 Feb 2007 Source: Monthly VPD MDB Measles Catch-up Campaign Phase1Phase2Phase3 Types of outbreaks Number of outbreaks Total outbreaks reported Serologically confirmed Measles Serologically confirmed Rubella Serologically confirmed Mixed 1120

Adding other interventions to measles SIAs CountryYearMeaslesRubellaOPVVit A Bed nets Sri Lanka2004 √√ Nepal2004/05 √ Under 5 Y Nationally Maldives2005 √√ Bhutan2006 √√ Indonesia 2005 √ Under 5 Y in 2 provinces 6-59 M In 2 provinces 2006 √ Under 5 Y in 9 provinces 6-59 M In 9 provinces Selected districts in 8 provinces

Summary of achievements Large countries emphasis on strengthening routine immunization and enhancing coverage Established integrated surveillance and regional lab network (16 labs) Major increase in reporting and outbreak investigations Catch up campaigns; above 95% coverage Notable examples: Nepal, Bangladesh, Bhutan, Indonesia Built strong partnerships: SEAM Identifying disease burden due to Rubella Integration of some public health interventions

Challenges/Issues Finishing polio – India and Bangladesh Funding for sustaining surveillance net works and SIAs in India Coordinate integration in large countries –Established programmes go alone e.g Vit A distribution in Nepal, Bangladesh and Myanmar –Logistic difficulties in delivering bed nets in time –Non availability of adequate stocks of OPV for large countries

Plans for India will be the focus Improving routine immunization to sustain gains of SIAs –c MYP –GAVI funded activities Surveillance –Initiate case based surveillance after SIA Nepal and Bangladesh in 2007 Indonesia and Myanmar in 2008 –India: Gradual expansion of measles surveillance to more states –Improving the monthly reporting to SEAR and commence monthly reporting to HQ WHO/UNICEF to ensure adequate technical support to the countries

SIA plan CountryTimeTarget areaAge group TargetIntegrated Interventions YEAR 2007 Indonesia FebruaryJava Island (catch-up) 6 M -12 y14,800,000Vit A, OPV AugustRemaining islands (Catch-up) 6 M -12 y5,400,000ITNs, Vit A, OPV MyanmarJan, Mach May National (Follow-up) 9 M -5 Y7,100,000 DPRKMarch - April National (Catch-up) 9 M-45Y16,200,000 Vit A Year 2008 Nepal *Q 4National (follow-up) 9-59 M3,700,000? Vit A, ?OPV Timor Leste * 2008National (Catch-up) 9 M-15 Y400,000? OPV India* * states (Catch-up) 9M-10 Y29,000,000? OPV * Subject to government confirmation

THANK YOU

Building on AFP Surveillance to Support Measles and Other VPD Surveillance, SEAR Updated September 2006 * Surveillance Officers partially supported by WHO ** Active surveillance also has passive surveillance components *** Countries submitting case-based also submit monthly aggregate

17 SEAR Measles laboratory Accreditation status 2006 CountryLaboratoryAccreditation status BangladeshDhakaAccredited BhutanThimpuProvisionally accredited DPRKPyonangPending IndiaBangaloreDue in 2007 ChennaiAccredited CoonoorAccredited HyderabadDue in 2007 IndonesiaBandungAccredited JakartaAccredited SurabayaAccredited YogyakartaAccredited MaldivesMaleNot accredited MyanmarYangoonAccredited NepalKathmanduProvisionally accredited ThailandBangkokAccredited Timor LesteDilliNot operational SrilankaColomboAccredited